Model
Edge
Arca Biopharma Inc.
ABIO
Filing Type
8-K
Filing Date
6/30/2025
Updated
7/1/25, 2:01 PM
Filing
8-K
Earnings Release
Exhibits
8-K
Changes in Board, Management or Compensation
EX-10.1
OFFER LETTER, DATED JULY 1, 2025, BETWEEN ORUKA THERAPEUTICS, INC. AND LAURA SANDLER.
GRAPHIC
Graphic